Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.14
-0.61 (-3.09%)
At close: Jul 10, 2026, 4:00 PM EDT
18.75
-0.39 (-2.04%)
After-hours: Jul 10, 2026, 7:51 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.04 billion as of July 10, 2026. Its market cap has increased by 1,397.05% in one year.
Market Cap
1.04B
Enterprise Value
548.53M
1-Year Change
1,397.05%
Ranking
Category
Stock Price
$19.14
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $1.04B, a decrease of -20.16%. That is a compound annual growth rate of -4.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.04B | 104.78% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 1.11B |
| Forte Biosciences | 1.07B |
| Olema Pharmaceuticals | 1.04B |
| Solid Biosciences | 1.03B |
| Kura Oncology | 1.02B |
| Avalo Therapeutics | 1.01B |
| Inventiva | 1.01B |
| Phathom Pharmaceuticals | 1.00B |